Novo Nordisk's cagrilintide shows promise in Phase 3 trial | Alan Nafiev posted on the topic US$ 20.52 Min. order: 1 piece ★★★★★ 4.0 (180 reviews) Sold : Login>>
Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.50 Min. order: 1 piece ★★★★★ 4.1 (231 reviews) Sold : Login>>
BPC-157 5mg: High Purity Research Peptide for Studies US$ 21.50 Min. order: 1 piece ★★★★★ 4.7 (86 reviews) Sold : Login>>